Literature DB >> 23661527

Successful treatment of thalidomide for recurrent bleeding due to gastric angiodysplasia in hereditary hemorrhagic telangiectasia.

X-Y Wang1, Y Chen, Q Du.   

Abstract

Hereditary hemorrhagic telangiectasia (HHT) is an autosomal dominant disorder, which is uncommon anomaly to recurrent gastrointestinal bleeding. Although there are several forms of therapy ranging from local therapy to operations or drug therapy, there is a lack of more effective treatment for the disease. In this report, we presented a Chinese patient with recurrent melena due to gastric angiodysplasia in HHT treated successfully with thalidomide.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23661527

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  8 in total

1.  Antiinflammation and Antioxidant Effects of Thalidomide on Pulmonary Fibrosis in Mice and Human Lung Fibroblasts.

Authors:  Xiaoying Dong; Xin Li; Minghui Li; Ming Chen; Qian Fan; Wei Wei
Journal:  Inflammation       Date:  2017-12       Impact factor: 4.092

2.  Surgical treatment of gastrointestinal hereditary hemorrhagic telangiectasia.

Authors:  Min-Hsuan Yen; Chiung-Nien Chen
Journal:  Acute Med Surg       Date:  2015-11-12

3.  Inhibitory effects of thalidomide on bleomycin-induced pulmonary fibrosis in rats via regulation of thioredoxin reductase and inflammations.

Authors:  Xiaoying Dong; Xin Li; Minghui Li; Ming Chen; Qian Fan; Wei Wei
Journal:  Am J Transl Res       Date:  2017-10-15       Impact factor: 4.060

Review 4.  Emerging role of thalidomide in the treatment of gastrointestinal bleeding.

Authors:  Michael McFarlane; Lauren O'Flynn; Rachel Ventre; Benjamin R Disney
Journal:  Frontline Gastroenterol       Date:  2017-11-02

Review 5.  Optimal management of hereditary hemorrhagic telangiectasia.

Authors:  Neetika Garg; Monica Khunger; Arjun Gupta; Nilay Kumar
Journal:  J Blood Med       Date:  2014-10-15

6.  Bleeding recurrence in patients with gastrointestinal vascular malformation after thalidomide.

Authors:  Haiying Chen; Sengwang Fu; Nan Feng; Huimin Chen; Yunjie Gao; Yunjia Zhao; Hanbing Xue; Yao Zhang; Xiaobo Li; Jun Dai; Jingyuan Fang; Zhizheng Ge
Journal:  Medicine (Baltimore)       Date:  2016-08       Impact factor: 1.889

7.  Thalidomide Effects in Patients with Hereditary Hemorrhagic Telangiectasia During Therapeutic Treatment and in Fli-EGFP Transgenic Zebrafish Model.

Authors:  Hong-Ling Peng; Yi-Fang Yi; Shun-Ke Zhou; Si-Si Xie; Guang-Sen Zhang
Journal:  Chin Med J (Engl)       Date:  2015-11-20       Impact factor: 2.628

8.  Gastrointestinal Bleeding in Patients with Hereditary Hemorrhagic Telangiectasia: Risk Factors and Endoscopic Findings.

Authors:  José María Mora-Luján; Adriana Iriarte; Esther Alba; Miguel Ángel Sánchez-Corral; Ana Berrozpe; Pau Cerdà; Francesc Cruellas; Jesús Ribas; Jose Castellote; Antoni Riera-Mestre
Journal:  J Clin Med       Date:  2019-12-28       Impact factor: 4.241

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.